CASR and malignant colon neoplasm: To investigate whether the pro-inflammatory effects of calcimimetics in the colon are indeed mediated via the CaSR, we used the colon cancer cell line HT29 transfected either with the CaSR (HT-29CaSR-GFP) or with the empty vector (HT29GFP).